Proton pump inhibitors and risk of periampullary cancers—A nested case–control study

Considerable attention has been focused on long‐term use of proton pump inhibitor (PPI) medications in relation to increased risk of cancer via stimulation of DNA‐damaged cells. The aim of this study is to examine the dose‐dependent effect of PPI on periampullary cancers in a national population‐bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Li‐Nien, Huang, Yan‐Jiun, Shao, Yu‐Hsuan Joni, Chang, Chen‐Jung, Chuang, Ming‐Tsang, Chiou, Hung‐Yi, Yen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738410/
https://www.ncbi.nlm.nih.gov/pubmed/26488896
http://dx.doi.org/10.1002/ijc.29896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738410/
https://www.ncbi.nlm.nih.gov/pubmed/26488896
http://dx.doi.org/10.1002/ijc.29896

Ejemplares similares